Anzeige
Mehr »
Montag, 13.10.2025 - Börsentäglich über 12.000 News
Der Mann, der ein Lithium-Unternehmen im Wert von 1,2 Milliarden Dollar aufgebaut hat, ist zurück...
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1JLYP | ISIN: KYG211081248 | Ticker-Symbol: 2M7C
Tradegate
08.10.25 | 15:15
1,580 Euro
+9,72 % +0,140
Branche
Gesundheitswesen
Aktienmarkt
ASIEN
1-Jahres-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD Chart 1 Jahr
5-Tage-Chart
CHINA MEDICAL SYSTEM HOLDINGS LTD 5-Tage-Chart
RealtimeGeldBriefZeit
1,4701,55021:48
1,4801,54021:50

Aktuelle News zur CHINA MEDICAL SYSTEM Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
30.09.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT APPROVAL OF DRUG CLINICAL TRIALS FOR ADDITIONAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE INDICATION ...-
28.09.China Medical System Holdings Ltd. (867.HK; 8A8.SG) Positive Results from China Phase 3 Clinical Trial of Innovative Drug Ruxolitinib Cream with AD Indication674SHENZHEN, CHINA, Sept. 28, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited ("CMS") is pleased to announce that its subsidiaries, Dermavon Holdings Limited ("Dermavon", an innovative...
► Artikel lesen
26.09.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT POSITIVE RESULTS FROM PHASE 3 CLINICAL TRIAL OF RUXOLITINIB CREAM IN CHINESE PATIENTS WITH ATOPIC ...3
26.09.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT APPROVAL OF DRUG CLINICAL TRIALS FOR UTERINE FIBROIDS INDICATION OF INNOVATIVE DRUG GNRH RECEPTOR ...-
23.09.China Medical System Holdings Ltd. (867.HK; 8A8.SG) Signed Collaboration Agreements for Two Innovative Biologics Used for Passive Immunization Against Tetanus and Rabies327SHENZHEN, CHINA, Sept. 23, 2025 (GLOBE NEWSWIRE) -- China Medical System Holdings Limited ("CMS" or the "Group") is pleased to announce that on 22 September 2025, the Group through its subsidiaries...
► Artikel lesen
CHINA MEDICAL SYSTEM Aktie jetzt für 0€ handeln
22.09.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT SIGNING COLLABORATION AGREEMENTS FOR CLASS 1 INNOVATIVE BIOLOGIC RECOMBINANT HUMANIZED ANTI-TETANUS ...1
02.09.CMS (00867): LETTER TO NON-REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS ...-
02.09.CMS (00867): LETTER TO REGISTERED SHAREHOLDERS - REMINDER LETTER REGARDING THE ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS AND ...-
02.09.CMS (00867): INTERIM REPORT 20251
28.08.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT APPROVAL OF DRUG CLINICAL TRIALS FOR VITILIGO AND HIDRADENITIS SUPPURATIVA INDICATION OF INNOVATIVE ...1
19.08.China Medical System H1 Net Profit Rises1
19.08.China Medical System Holdings Ltd.: CMS (867.HK, 8A8.SG) Reports Growth in Revenue and Profit for H1 2025, Strategic Transformation Unlocks New Drivers771 SHENZHEN, CHINA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- On 18 August, China Medical System Holdings Limited ("CMS" or the "Company") announced its interim results for the six months ended 30 June 2025...
► Artikel lesen
19.08.China Medical System profit up 3.1% in H14
18.08.CMS (00867): LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION2
18.08.CMS (00867): INTERIM DIVIDEND FOR THE SIX MONTHS ENDED 30 JUNE 2025-
18.08.CMS (00867): INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2025 AND RESIGNATION OF NON-EXECUTIVE DIRECTOR1
06.08.CMS (00867): NOTICE OF BOARD MEETING1
28.07.China Medical System Holdings Ltd. (867.HK, 8A8.SG)NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China1
28.07.CMS (00867): VOLUNTARY AND BUSINESS UPDATE ANNOUNCEMENT NEW DRUG APPLICATION FOR THE TREATMENT OF MILD-TO-MODERATE DEMENTIA OF THE ALZHEIMER'S TYPE OF ...1
23.07.China Medical System Holdings Ltd boosts global presence with Singapore Exchange listing4
Weiter >>
41 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1